Acadian Asset Management’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,819
| Closed | -$123K | – | 1839 |
|
|
2021
Q4 | $123K | Buy |
+4,819
| New | +$123K | ﹤0.01% | 1335 |
|
|
2020
Q3 | – | Sell |
-1,742
| Closed | -$138K | – | 2391 |
|
|
2020
Q2 | $138K | Sell |
1,742
-627
| -26% | -$49.7K | ﹤0.01% | 1620 |
|
|
2020
Q1 | $80K | Buy |
2,369
+925
| +64% | +$31.2K | ﹤0.01% | 1399 |
|
|
2019
Q4 | $99K | Hold |
1,444
| – | – | ﹤0.01% | 1463 |
|
|
2019
Q3 | $93K | Hold |
1,444
| – | – | ﹤0.01% | 1504 |
|
|
2019
Q2 | $128K | Buy |
1,444
+429
| +42% | +$38K | ﹤0.01% | 1329 |
|
|
2019
Q1 | $82K | Buy |
1,015
+304
| +43% | +$24.6K | ﹤0.01% | 1570 |
|
|
2018
Q4 | $51K | Buy |
711
+80
| +13% | +$5.74K | ﹤0.01% | 1422 |
|
|
2018
Q3 | $76K | Buy |
631
+166
| +36% | +$20K | ﹤0.01% | 1274 |
|
|
2018
Q2 | $56K | Hold |
465
| – | – | ﹤0.01% | 1369 |
|
|
2018
Q1 | $50K | Buy |
+465
| New | +$50K | ﹤0.01% | 1354 |
|